참고문헌
- Abelev GI, Perova SD, Khramkova NI, et al (1963). Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation, 1, 174-80. https://doi.org/10.1097/00007890-196301020-00004
- Augusto E, Matos M, Sevigny J, et al (2013). Ecto-5'- nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. J Neurosci, 33, 11390-9. https://doi.org/10.1523/JNEUROSCI.5817-12.2013
- Bae JS, Park SJ, Park KB, et al (2005). Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alphafetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med, 20, 80-5. https://doi.org/10.3904/kjim.2005.20.1.80
- Bates SE (1991). Clinical applications of serum tumor markers. Ann Intern Med, 115, 623-38. https://doi.org/10.7326/0003-4819-115-8-623
- Bergstrand CG, Czar B (1956). Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest, 8, 174. https://doi.org/10.3109/00365515609049266
- Bertino G, Ardiri A, Malaguarnera M, et al (2012). Hepatocellualar carcinoma serum markers. Semin Oncol, 39, 410-33. https://doi.org/10.1053/j.seminoncol.2012.05.001
- Carr BI, Guerra V, Giannini EG, et al (2014). Significance of platelet and AFP levels and liver function parameters for HCC size and survival. Int J Biol Markers, 29, e215-23.
- Chatterjee SK, Kim U, Bielat K (1976). Plasma membrane associated enzymes of mammary tumours as the biochemical indicators of metastasizing capacity. Analyses of enriched plasma membrane preparations. Br J Cancer, 33, 15-26. https://doi.org/10.1038/bjc.1976.3
- El-Attar HA, Kandil MH, El-Kerm YM, et al (2010). Comparison of serum survivin and alpha fetoprotein in Egyptian patients with hepatocellular carcinoma associated with hepatitis C viral infection. Asian Pac J Cancer Prev, 11, 897-903.
- El-Serag HB, Marrero JA, Rudolph L, et al (2008). Diagnosis and treatment of hepatocellular carcinoma. Gastroenterol, 134, 1752-63. https://doi.org/10.1053/j.gastro.2008.02.090
- Fausther M, Sheung N, Saiman Y, et al (2012). Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/ CD73 via specific SP1 and SMAD promoter elements. Am J Physiol Gastrointest Liver Physiol, 303, 904-14. https://doi.org/10.1152/ajpgi.00015.2012
- Gan Y, Liang Q, Song X (2014). Diagnostic value of alpha-Lfucosidase for hepatocellular carcinoma: a meta-analysis. Tumour Biol, 35, 3953-60. https://doi.org/10.1007/s13277-013-1563-8
- Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
- Gornall AG, Bardawill CJ, David MM (1949). Determination of serum proteins by means of the biuret reaction. J Biol Chem, 177, 751-66.
- Hunsucker SA, Mitchell BS, Spychala J (2005). The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther, 107, 1-30. https://doi.org/10.1016/j.pharmthera.2005.01.003
- IuS T (1964). Detection of embryo-specific alpha-globulin in the blood serum of a patient with primary liver cancer. Vopr Med Khim, 10, 90-1 (in Russian).
- Kuang Y, Salem N, Wang F, et al (2007). A colorimetric assay method to measure acetyl-CoA synthetase activity: application to woodchuck model of hepatitis virus-induced hepatocellular carcinoma. J Biochem Biophys Methods, 70, 649-55. https://doi.org/10.1016/j.jbbm.2007.02.008
- Lee HS, Chung YH, Kim CY (1991). Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Hepatol, 14, 68-72. https://doi.org/10.1002/hep.1840140112
- Llovet JM, Pena CE, Lathia CD, et al (2012). Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res, 18, 2290-300. https://doi.org/10.1158/1078-0432.CCR-11-2175
- Lok AS, Sterling RK, Everhart JE, et al (2010). Des-gammacarboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterol, 138, 493-502. https://doi.org/10.1053/j.gastro.2009.10.031
- Malaguarnera G, Giordano M, Paladina I, et al (2010). Serum markers of hepatocellular carcinoma. Dig Dis Sci, 55, 2744-55. https://doi.org/10.1007/s10620-010-1184-7
- Martinek RG, Berger L, Broida D (1964). Simplified Estimation of Leucine Aminopeptidase (Lap) Activity. Clin Chem, 10, 1087-97.
- Matsui M, Fowler JH, Walling LL (2006). Leucine aminopeptidases: diversity in structure and function. Biol Chem, 387, 1535-44.
- Mazzon C, Rampazzo C, Scaini MC, et al (2003). Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. Biochem Pharmacol, 66, 471-9. https://doi.org/10.1016/S0006-2952(03)00290-9
- Mittal A, Sathian B, Chandrashekharan N, et al (2011). Diagnostic significance of alpha fetoprotein in carcinomas of liver and biliary tract - a comparative study from the western region of Nepal. Asian Pac J Cancer Prev, 12, 3475-8.
- Mizutani S, Shibata K, Kikkawa F, et al (2007). Essential role of placental leucine aminopeptidase in gynecologic malignancy. Expert Opin Ther Targets, 11, 453-61. https://doi.org/10.1517/14728222.11.4.453
- Oses JP, Cardoso CM, Germano RA, et al (2004). Soluble NTPDase: An additional system of nucleotide hydrolysis in rat blood serum. Life Sci, 74, 3275-84. https://doi.org/10.1016/j.lfs.2003.11.020
- Richardson P, Duan Z, Kramer J, et al (2012). Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol, 10, 428-33. https://doi.org/10.1016/j.cgh.2011.11.025
- Sangro B, Salem R, Kennedy A, et al (2011). Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol, 34, 422-31. https://doi.org/10.1097/COC.0b013e3181df0a50
- Sathe SB, Taskar SP (1982). Leucine amino peptidase levels in hepatic and certain gastro intestinal tract cancers. J Assoc Physicians India, 30, 83.
- Sato Y, Nakata K, Kato Y, et al (1993). Early recognition of hepatocellular carcinoma based on altered profiles of alphafetoprotein. N Engl J Med, 328, 1802-6. https://doi.org/10.1056/NEJM199306243282502
- Schieving JH, de Vries M, van Vugt JM, et al (2014). Alphafetoprotein, a fascinating protein and biomarker in neurology. Eur J Paediatr Neurol, 18, 243-8. https://doi.org/10.1016/j.ejpn.2013.09.003
- Soresi M, Magliarisi C, Campagna P, et al (2003). Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res, 23, 1747-53.
- Taketa K (1990). Alpha-fetoprotein: reevaluation in hepatology. Hepatol, 12, 1420-32. https://doi.org/10.1002/hep.1840120625
- Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al (2000). Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol, 31, 302-8. https://doi.org/10.1097/00004836-200012000-00007
- Tian L, Wang Y, Xu D, et al (2011). Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases. Int J Cancer, 129, 1923-31. https://doi.org/10.1002/ijc.25838
- Tian SY, Chen SH, Shao BF, et al (2014). Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC). Int J Clin Exp Pathol, 7, 3752-62.
- Trinchet JC, Chaffaut C, Bourcier V, et al (2011). Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology, 54, 1987-97. https://doi.org/10.1002/hep.24545
- Tripathi V, Shen Z, Chakraborty A, et al (2013). Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet, 9, 1003368. https://doi.org/10.1371/journal.pgen.1003368
- Wang NY, Wang C, Li W, et al (2014). Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation. Asian Pac J Cancer Prev, 15, 1539-44. https://doi.org/10.7314/APJCP.2014.15.4.1539
- Wu JC, Lee SD, Hsiao KJ, et al (1988). Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan--a dried blood spot method. Liver, 8, 100-4.
- Xu J, Liu C, Zhou L, et al (2012). Distinctions between clinicopathological factors and prognosis of alphafetoprotein negative and positive hepatocelluar carcinoma patients. Asian Pac J Cancer Prev, 13, 559-62. https://doi.org/10.7314/APJCP.2012.13.2.559
- Xu J, Liu C, Zhou L, et al (2012). Distinctions between clinicopathological factors and prognosis of alphafetoprotein negative and positive hepatocelluar carcinoma patients. Asian Pac J Cancer Prev, 13, 559-62. https://doi.org/10.7314/APJCP.2012.13.2.559
- Yegutkin GG (1997). Kinetic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochemistry, 62, 619-22.
- Zhai X, Zhu H, Wang W, et al (2014). Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med Oncol, 31, 970. https://doi.org/10.1007/s12032-014-0970-z
- Zhou L, Liu J, Luo F (2006). Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol, 12, 1175-81. https://doi.org/10.3748/wjg.v12.i8.1175
- Zhu K, Dai Z, Pan Q, et al (2011). Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res, 17, 7294-302. https://doi.org/10.1158/1078-0432.CCR-11-1327
피인용 문헌
- Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4769